Assessing the impact of brachytherapy boost in intermediate-risk, early-stage cervical cancer treatment

被引：0
|
作者：
Agusti, Nuria [1 ]
Viveros-Carreno, David [2 ]
Melamed, Alexander [3 ]
Pareja, Rene [2 ]
Wu, Chi-Fang [1 ]
Kanbergs, Alexa [1 ]
Rauh-Hain, Jose [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Inst Nacl Cancerol, Bogota, Colombia
[3] Columbia Univ, Vagelos Coll Phys & Surg, Boston, MA USA
来源：
GYNECOLOGIC ONCOLOGY | 2024年 / 190卷
关键词：
D O I：
10.1016/j.ygyno.2024.07.557
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2266
引用
收藏
页码：S375 / S376
页数：2
相关论文
共 50 条
  • [41] Delayed adjuvant radiotherapy in early-stage cervical cancer with intermediate-risk features has a detrimental effect on survival that cannot be corrected by adjuvant chemotherapy.
    Kodiyan, Joyson
    Guirguis, Adel
    Ashmalla, Hani
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [42] IMPACT OF VAGINAL CUFF BRACHYTHERAPY IN OPERATED PATIENTS WITH HIGH RISK EARLY STAGE CERVICAL CANCER
    Mauro, G.
    Kleine Truffa, R.
    Silva Cabral Severino, S.
    Carvalho de Andrade, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A84 - A85
  • [43] Early-stage high-risk endometrial cancer: Adjuvant treatment with chemotherapy and vaginal brachytherapy
    Schuman, S.
    Stine, J.
    Zhao, W.
    Yali, P.
    Wolfson, A.
    Lucci, J.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S86 - S87
  • [44] Brachytherapy for Intermediate-Risk Prostate Cancer, Androgen Deprivation, and the Risk of Death
    Pickles, Tom
    Tyldesley, Scott
    Hamm, Jeremy
    Virani, Sean A.
    Morris, W. James
    Keyes, Mira
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (01): : 45 - 52
  • [45] Early-stage intermediate-risk-the group with the most heterogenous management among patients with cervical cancer
    Cibula, David
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (10) : 1227 - 1228
  • [46] Is There Still a Place for Brachytherapy in the Modern Treatment of Early-Stage Oral Cancer?
    Tucek, Lubos
    Vosmik, Milan
    Petera, Jiri
    CANCERS, 2022, 14 (01)
  • [47] Point: There is a need for supplemental XRT with brachytherapy in the treatment of intermediate-risk prostate cancer patients
    Spratt, Daniel E.
    Zelefsky, Michael J.
    BRACHYTHERAPY, 2013, 12 (05) : 389 - 392
  • [48] Point: Vaginal brachytherapy should be a standard adjuvant treatment for intermediate-risk endometrial cancer
    Nout, Remi A.
    Creutzberg, Carien L.
    BRACHYTHERAPY, 2011, 10 (01) : 1 - 3
  • [49] Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer
    Philp, L.
    Tannenbaum, S.
    Haber, H.
    Saini, A.
    St Laurent, J.
    James, K.
    Feltmate, C. M.
    Russo, A. L.
    Growdon, W. B.
    GYNECOLOGIC ONCOLOGY, 2021, 160 (02) : 389 - 395
  • [50] The baseline recurrence risk of patients with intermediate-risk cervical cancer
    Yoneoka, Yutaka
    Kato, Mayumi Kobayashi
    Tanase, Yasuhito
    Uno, Masaya
    Ishikawa, Mitsuya
    Murakami, Takashi
    Kato, Tomoyasu
    OBSTETRICS & GYNECOLOGY SCIENCE, 2021, 64 (02) : 226 - 233
12345